HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ACH

Accendra Health, Inc. (NYSE)

Healthcare — Medical Distribution

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

None 5 analysts
$3.46
+$0.16 (+1.32%)
Target: $4.49 (29.6%)
Sign in to add ACH to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$271.87M
P/E Ratio (TTM)-
Forward P/E5.16
EPS (TTM)$-1.37
Dividend Yield-
Profit Margin-39.84%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation None
Analyst Target$4.49
Analysts5
Indexes NYSE

Technical Indicators

RSI (14)72.0
Beta1.63
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume-
Volume-

Performance Analysis

NEUTRAL

ACH presents a mixed picture with both positive and negative indicators.

- RSI at 72.0 indicates overbought conditions — a pullback may be due.
- Operating at a loss with -39.8% margin.
~ Wall Street consensus is "none" from 5 analysts.
+ Average analyst target of $4.49 implies 29.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 15:01 UTC

Back to Screener Export Report